Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source
Showing the last 5 quarters. 35 more quarters, back to Dec 2016, with Tormere Pro.
Informational purposes only, not investment advice.
cbdMD, Inc. (YCBD)
tormere.com/research/YCBD · generated 2026-11-05
$0.41
-3.10%
General Information
Price$0.41
Change-3.10%
Market Cap$5M
SectorHealth Care
IndustryPharmaceuticals
ExchangeNYSE
Beta (raw, 60mo vs SPY)2.29
Signals
Insider Velocity—
Congress Trades (90d)—
Short Volume
41% of daily vol
Conviction Score—
Price Chart (1 Year)
Recent News
A director nomination right accompanies Akretive’s share acquisition in cbdMD (YCBD). — Stock Titan · 2026-11-05
A 10% owner reports its cbdMD (YCBD) stake following an acquisition effective October 30. — Stock Titan · 2026-11-05
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness — Yahoo · 2026-11-02
12 Health Care Stocks Moving In Wednesday's After-Market Session — Benzinga · 2026-10-28
12 Health Care Stocks Moving In Thursday's Pre-Market Session — Benzinga · 2026-10-15
Tormere — informational purposes only, not investment advice.
